GSK Posts Strong Results, Says 'Well Positioned' in Case of Pharma Tariffs

  • U.S.-listed shares of GSK (GSK) are gaining in premarket trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the Trump administration imposes tariffs against the industry.